{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:31:26Z","timestamp":1794652286110,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jemermed.2021.02.006","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T22:34:49Z","timestamp":1616193289000},"page":"743-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9116-6828","authenticated-orcid":false,"given":"Katelin","family":"Morrissette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bridwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-3261","authenticated-orcid":false,"given":"Skyler","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Olmedo","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2021.02.006_bib1","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2021.02.006_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.jemermed.2021.02.006_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12032-013-0740-3","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a review of literature","volume":"30","author":"Mehta","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2009.02.050","article-title":"Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan","volume":"155","author":"Suzuki","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jemermed.2021.02.006_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/pbc.25308","article-title":"Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden","volume":"62","author":"Meeths","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jemermed.2021.02.006_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/art.41106","article-title":"To \u201clump\u201d or to \u201csplit\u201d in macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"72","author":"Nikiforow","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bjh.14144","article-title":"Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options","volume":"174","author":"Brisse","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00432-020-03139-4","article-title":"Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry","volume":"146","author":"Birndt","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1658-5127.155168","article-title":"Is secondary hemophagocytic lymphohistiocytosis behind the high fatality rate in Middle East respiratory syndrome corona virus?","volume":"6","author":"Al-Ahmari","year":"2015","journal-title":"J Appl Hematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00296-020-04636-y","article-title":"Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic","volume":"41","author":"Soy","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jemermed.2021.02.006_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society","volume":"6","author":"Ehl","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jemermed.2021.02.006_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jemermed.2021.02.006_bib15","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2021.02.006_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/0885066617711386","article-title":"Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis","volume":"34","author":"Wohlfarth","year":"2019","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib17","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.clml.2018.06.014","article-title":"Prognostic factors and outcomes in adults with secondary hemophagocytic lymphohistiocytosis: a single-center experience","volume":"18","author":"Apodaca","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jemermed.2021.02.006_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","article-title":"Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis","volume":"89","author":"Parikh","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jemermed.2021.02.006_bib19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.amjmed.2014.04.034","article-title":"Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients","volume":"127","author":"Riviere","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib20","doi-asserted-by":"crossref","first-page":"e27929","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jemermed.2021.02.006_bib21","first-page":"31","article-title":"Hemophagocytic lymphohistiocytosis mimics many common conditions: case series and review of literature","volume":"49","author":"Akenroye","year":"2017","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jemermed.2021.02.006_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.5858\/2001-125-0888-EOCAWA","article-title":"Evaluation of characteristics associated with acute splenitis (septic spleen) as markers of systemic infection","volume":"125","author":"Feig","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib24","doi-asserted-by":"crossref","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","article-title":"Causes and significance of markedly elevated serum ferritin levels in an academic medical center","volume":"19","author":"Moore","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqw053","article-title":"Extreme hyperferritinemia: causes and impact on diagnostic reasoning","volume":"145","author":"Sackett","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/imj.12768","article-title":"Conditions associated with extreme hyperferritinaemia (>3000 mug\/L) in adults","volume":"45","author":"Wormsbecker","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.jemermed.2021.02.006_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","article-title":"Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis","volume":"96","author":"Otrock","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/ejh.13391","article-title":"Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis","volume":"104","author":"Naymagon","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4081\/reumatismo.2019.1221","article-title":"Extreme hyperferritinemia: etiological spectrum and impact on prognosis","volume":"71","author":"Belfeki","year":"2020","journal-title":"Reumatismo"},{"key":"10.1016\/j.jemermed.2021.02.006_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jemermed.2021.02.006_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","article-title":"Performances of the H-Score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients","volume":"145","author":"Debaugnies","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib35","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib36","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.3324\/haematol.2019.222471","article-title":"Ruxolitinib for refractory\/relapsed hemophagocytic lymphohistiocytosis","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jemermed.2021.02.006_bib37","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/cc10073","article-title":"Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection","volume":"15","author":"Beutel","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2021.02.006_bib38","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PCC.0000000000000460","article-title":"How we manage hyperferritinemic sepsis-related multiple organ dysfunction syndrome\/macrophage activation syndrome\/secondary hemophagocytic lymphohistiocytosis histiocytosis","volume":"16","author":"Carcillo","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib39","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jemermed.2021.02.006_bib40","doi-asserted-by":"crossref","first-page":"102562","DOI":"10.1016\/j.autrev.2020.102562","article-title":"Cytokine storm syndrome in severe COVID-19","volume":"19","author":"Ruscitti","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jemermed.2021.02.006_bib41","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","article-title":"Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets","volume":"39","author":"Misra","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3949\/ccjm.87a.ccc008","article-title":"Cytokine storm and the prospects for immunotherapy with COVID-19","volume":"87","author":"Calabrese","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jemermed.2021.02.006_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2021.02.006_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib45","doi-asserted-by":"crossref","first-page":"e00829","DOI":"10.1016\/j.idcr.2020.e00829","article-title":"A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm)","volume":"21","author":"Chhetri","year":"2020","journal-title":"IDCases"},{"key":"10.1016\/j.jemermed.2021.02.006_bib46","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S0140-6736(20)31057-6","article-title":"Is the HScore useful in COVID-19?","volume":"395","author":"Leverenz","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2021.02.006_bib47","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00011-020-01372-8","article-title":"The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of \u201cinflame-aging\u201d","volume":"69","author":"Meftahi","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jemermed.2021.02.006_bib48","doi-asserted-by":"crossref","first-page":"108448","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jemermed.2021.02.006_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","article-title":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza","volume":"213","author":"Schulert","year":"2016","journal-title":"J Infect Dis"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467921001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467921001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:55Z","timestamp":1760028475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467921001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0736467921001074"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.02.006","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}